凱普生物(300639.SZ)及子公司獲得一項發明專利
格隆匯9月28日丨凱普生物(300639.SZ)公佈,近日,公司、全資子公司廣州凱普醫藥科技有限公司(“凱普醫藥”)以及控股子公司成都凱普醫學檢驗所有限公司(“成都凱普醫學檢驗所”)、鄭州凱普醫學檢驗所(有限合夥)(“鄭州凱普醫學檢驗所”)收到國家知識產權局下發的《授予發明專利權通知書》,具體情況如下:

該發明提供了一種檢測新型冠狀病毒的引物探針組合及其應用,所述檢測新型冠狀病毒的引物探針組合包括特異性擴增並檢測2019-nCoV的ORF1ab基因、核殼蛋白N基因和刺突蛋白S基因N501Y突變位點的特異性引物對和探針。該發明還提供了一種檢測新型冠狀病毒的試劑盒及其以非疾病診斷和/或治療為目的的使用方法。
公司已運用該發明專利技術開發相關產品新型冠狀病毒2019-nCoV變異位點/通用核酸檢測試劑盒(PCR-熒光探針法)(產品英文名稱:COVID-19 variants detection Kit),上述產品已獲得歐盟CE認證並已進入中國醫藥保健品進出口商會發布的《取得國外標準認證或註冊的醫療物資生產企業清單》,可出口到歐盟市場,但目前尚未取得國內醫療器械註冊證。這是國際市場對公司產品品質的認可,有利於進一步提升公司的國際競爭力,有利於公司助力國際新型冠狀病毒感染的肺炎疫情防控工作。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.